Skip to main content
logo
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.120
+0.010 (0.90%)
At close: Sep 17, 2026, 4:00 PM EDT
1.130
+0.010 (0.89%)
After-hours: Sep 17, 2026, 7:49 PM EDT

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $47.00M in the twelve months ending June 30, 2026, down -3.25% year-over-year. In the year 2025, Spero Therapeutics had annual revenue of $66.80M with 39.24% growth.

Revenue (ttm)
$47.00M
Revenue Growth
-3.25%
P/S Ratio
1.39
Revenue / Employee
$1,879,880
Employees
25
Market Cap
65.22M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202566.80M18.83M39.24%
Dec 31, 202447.98M-55.80M-53.77%
Dec 31, 2023103.78M50.27M93.95%
Dec 31, 202253.51M35.25M193.10%
Dec 31, 202118.26M8.93M95.67%
Dec 31, 20209.33M-8.82M-48.59%
Dec 31, 201918.15M14.18M357.56%
Dec 31, 20183.97M1.99M100.40%
Dec 31, 20171.98M1.64M490.75%
Dec 31, 2016335.00K--
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Gossamer Bio53.29M
Alps Group3.74M
Alterity Therapeutics2.50M
Serina Therapeutics130.00K
INmune Bio50.00K
Revenue Rankings

SPRO News

More News